my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
OctoPlus is a drug delivery and drug development company that is globally renowned for its expertise and professionalism. Since our inception in 1995, we have established a successful track record and maintain partnerships with large and small biotech and pharma companies throughout the world. Our more
Dr. Reddy's and OctoPlus jointly announced that they have reached conditional agreement in connection with an intended public offer by Dr. Reddy's, or a wholly owned subsidiary of Dr. Reddy's, for all issued and outstanding ordinary shares in the capital of OctoPlus at an offer price of € 0.52 (cum more
OctoPlus N.V. announces that the Supervisory Board of the Company will nominate Catherine Moukheibir to be appointed as member of the Supervisory Board at the next General Meeting of Shareholders. This appointment will be for a period of four years. Catherine Moukheibir MA, MBA, age 52, was CFO of M more
OctoPlus N.V. announced that a formulation development and manufacturing contract has been signed with Ferring Pharmaceuticals A/S. The undisclosed contract value will make a material contribution to OctoPlus' 2012 revenues. Further details on the compound and activities are not disclosed. more
OctoPlus N.V. (OctoPlus) operates as a drug delivery company, engaged in the development of improved pharmaceutical products. The company's business activities include formulation development services, drug delivery technologies and controlled release product development. It products portfolio inclu more
Syntaxin's Board of Directors Biotechnology Company About Syntaxin Biopharmaceutical Product Pipeline Biotech Research & Development Bio Tech News Contact Biopharmaceutical Firm Biotech Company About Us History Board of Directors Management Team Investors Scientific Advisory Board ddsdas Syntaxin's more
Home About us Pipeline Partners Investor relations Newsroom Careers Contact Vision Goals Management Board Quality Policy Dr. Manja Bouman has been Chief Executive Officer of Kiadis Pharma since 2004. Prior to joining Kiadis Pharma, Dr. Manja Bouman was Vice President Licensing and Technology at DSM more
Products Service Partners About us News Extras Active Pharmaceutical Ingredients Intermediates Custom Synthesis Contract Manufacture Dossiers Self-Medication Platform Technologies Our Partners for Platform Technologies. Innovative platform technologies which are capable of yielding new opportunities more
Watchlist
This is where you can add this topic to your personal favourites
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
